Skip to main content

Table 3 Multivariate Cox regression model fitting results by acceptance of chemotherapy in advanced PDAC patients

From: Prognostic relevance of lactate dehydrogenase in advanced pancreatic ductal adenocarcinoma patients

Independent variables Chemotherapy group Non-chemotherapy group
Crude HR (95% CI) Adjusted HR (95% CI) Crude HR (95% CI) Adjusted HR (95% CI)
Age at diagnosis (+5 years) 1.09 (0.94–1.25) 1.06 (0.94–1.20) 1.17 (1.03–1.33) 1.14 (1.00–1.30)
Sex (Male) 0.64 (0.38–1.07) 0.67 (0.39–1.14) 0.90 (0.53–1.55) 0.89 (0.50–1.56)
Baseline albumin (Decreased) 3.14 (1.67–5.89) 3.27 (1.70–6.27) 1.24 (0.62–2.47) 1.06 (0.51–2.21)
Baseline LDH (Elevated) 2.34 (1.23–4.45) 2.47 (1.28–4.77) 1.91 (1.04–3.47) 1.57 (0.83–2.96)